Roundup has been found to be a “significant factor” in a cancer patient who has successfully sued Bayer which bought Roundup’s maker, Monsanto, for $63 billion US.
It was the second jury verdict against Roundup, both in California, and prompted Bayer to issue a warning to stockholders that it faces 11,200 lawsuits filed by farmers, landscapers and gardeners.
As in the first case, this one in San Francisco found that Roundup was implicated in a case of non-Hodgins lymphoma.
Bayer’s stock price fell by 12 per cent Wednesday.
Bayer continues to insist that Roundup is safe.
